Sunshine Lake Pharma Co., Ltd.

Huichao Luo

Yingjun Zhang

Qingyun Ren

Jiancun Zhang

Hongming Xie

Yumei Tan

Xuechen Li

Changhua Tang

Kai Yi

Junjun Yin

Yejun Wang

Yibo Lei

Bailin Hu

Xiwei Wu

Zhimin Xiong

Tianzhu Yu

Shifeng Li

Changping Fu

Qinghong Fang

Chenglin Wang

Ali Huang

Xianwu Fu

Yong Lei

Quanxing Yu

Pharmaceuticals, and specifically a Teixobactin analogue and use thereof. A pharmaceutical composition having the compound and use of the compound and the pharmaceutical composition thereof inhibits the growth and/or reproduction of Gram-positive bacteria or. A compound has Formula (Ia) or a stereoisomer, a tautomer, an N-oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof,

Teixobactin analogue and use thereof

Disclosed are a compound as shown in formula (I) as an influenza virus replication inhibitor and a preparation method therefor, a pharmaceutical composition comprising the compound and the use of the compound and pharmaceutical composition thereof in the treatment of influenza. 

Influenza virus replication inhibitor and use thereof

Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder. 

Bridged ring compounds as hepatitis C virus (HCV) inhibitors and pharmaceutical applications thereof

Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease. 

Spiro compounds as Hepatitis C virus inhibitors

Growing community of inventors

Dongguan, China

Huichao Luo